| AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome S Suzuki-Hatano, M Saha, SA Rizzo, RL Witko, BJ Gosiker, ... Human gene therapy 30 (2), 139-154, 2019 | 53 | 2019 |
| Cardiovascular disease risk among transgender women living with HIV in the United States BJ Gosiker, CR Lesko, AJ Rich, HM Crane, MM Kitahata, SL Reisner, ... PloS one 15 (7), e0236177, 2020 | 13 | 2020 |
| One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle CA Pacak, S Suzuki-Hatano, F Khadir, AL Daugherty, M Sriramvenugopal, ... Journal of Translational Medicine 21 (1), 748, 2023 | 1 | 2023 |
| Pre-Clinical Development of AAV-Mediated TAZ Gene Delivery to Treat Barth Syndrome S Suzuki-Hatano, S Rizzo, M Saha, M Ramanathan, B Gosiker, M Soustek, ... MOLECULAR THERAPY 25 (5), 29-29, 2017 | 1 | 2017 |
| Changes in blood lipids following initiation of gender affirming hormone therapy: A systematic review and meta-analysis B Gosiker, J Moutchia, N Nguyen, D Getahun, M Goodman Journal of Clinical & Translational Endocrinology, 100349, 2024 | | 2024 |
| If You Don’t Ask, You Don’t Count: Elements to Consider in Understanding Global Sexual and Gender Minority Data on Noncommunicable Diseases JA McElroy, BJ Gosiker Global LGBTQ Health: Research, Policy, Practice, and Pathways, 79-92, 2024 | | 2024 |
| Sexual and Gender Minority Population’s Health Burden of Five Noncommunicable Diseases: Cardiovascular Disease, Cancer, Diabetes, Asthma, Chronic Obstructive Pulmonary Disease JA McElroy, BJ Gosiker Global LGBTQ Health: Research, Policy, Practice, and Pathways, 93-145, 2023 | | 2023 |
| AAV-Mediated TAZ Gene Replacement Restores Cardioskeletal Function and Improves Aberrant Proteomic Profiles in Barth Syndrome SS Hatano, M Saha, S Rizzo, R Witko, B Gosiker, M Ramanathan, ... MOLECULAR THERAPY 26 (5), 301-301, 2018 | | 2018 |
| 358. AAV-MitoTimer to Asses Mitochondrial Turnover B Gosiker, S Rizzo, A Donate, C Pacak Molecular Therapy 24, S143, 2016 | | 2016 |
| 187. AAV Delivery of Tafazzin for the Correction of Mitochondrial Dysfunction in Barth Syndrome Using IPS Differentiated Cardiomyocytes AL Donate, M Soustek, SA Rizzo, K Santostefano, BJ Gosiker, AS Lewin, ... Molecular Therapy 23, S75, 2015 | | 2015 |
| 182. Characterization and AAV-Mediated Correction of Xeroderma Pigmentosum-Cockayne Syndrome (XP/CS) SA Rizzo, AL Donate, BJ Gosiker, KE Santostefano, N Terada, ... Molecular Therapy 23, S73, 2015 | | 2015 |
Tonia Poteat, PhD, MPH, PA-CProfessor, Duke UniversityVerified email at duke.edu
